Home » NISSAN CHEMICAL INDUSTRIES, TEIJIN PHARMA TO COLLABORATE IN DEVELOPING DRUG CANDIDATE
NISSAN CHEMICAL INDUSTRIES, TEIJIN PHARMA TO COLLABORATE IN DEVELOPING DRUG CANDIDATE
August 11, 2005
Nissan Chemical Industries and Teijin Pharma jointly have reached a basic agreement to collaborate in developing a drug candidate discovered by the former. Specifically, the two companies aim to develop an agent for the treatment of atrial fibrillation and flutter. They plan to start a Phase I clinical trial in 2007. Further details are to be finalized later on.
Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=10660)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct